Toceranib

Toceranib is a tyrosine kinase inhibitor used for treating certain types of cancer in animals, primarily dogs. It is employed in the treatment of mast cell tumors and other solid tumors. Read more

Toceranib is a tyrosine kinase inhibitor used for treating certain types of cancer in animals, primarily dogs. It is employed in the treatment of mast cell tumors and other solid tumors.

Essential insights

• Inhibition of Tyrosine Kinases: Toceranib blocks tyrosine kinases, enzymes that play a key role in signaling for tumor cell growth and survival.
• Inhibition of Angiogenesis: By targeting vascular endothelial growth factor receptors (VEGFR), toceranib reduces blood supply to tumors, thereby inhibiting tumor growth.
• Selective Action: Toceranib primarily affects cancer cells and endothelial cells, minimizing damage to healthy cells.